1,518
Views
10
CrossRef citations to date
0
Altmetric
Cornea and Ocular Surface

Evaluation of the Ocular Surface Disease Index Questionnaire as a Discriminative Test for Clinical Findings in Dry Eye Disease Patients

ORCID Icon, , , , , , , , & show all
Pages 941-947 | Received 13 Dec 2018, Accepted 31 Mar 2019, Published online: 29 Apr 2019

References

  • Rahman MQ, Chuah KS, Macdonald ECA, Trusler JPM, Ramaesh K. The effect of pH, dilution, and temperature on the viscosity of ocular lubricants[mdash]shift in rheological parameters and potential clinical significance. Eye. 2012;26(12):1579–84. doi:10.1038/eye.2012.211.
  • Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo C-K, Liu Z, Nelson JD, Nichols JJ. Tsubota K and others. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15(3):276–83. doi:10.1016/j.jtos.2017.05.008.
  • Nelson JD, Helms H, Fiscella R, Southwell Y, Hirsch JD. A new look at dry eye disease and its treatment. Adv Ther. 2000;17:84–93.
  • Fd PT, Fernandes RS, Bernardes TF, Bonfioli AA, Carneiro Soares EJ. Dry eye disease. Semin Ophthalmol. 2010;25(3):84–93. doi:10.3109/08820538.2010.488568.
  • Bron AJ, Abelson MB, Ousler G, Pearce E, Tomlinson A, Yokoi N, Smith JA, Begley C, Caffery B, Nichols K. Methodologies to diagnose and monitor dry eye disease. Ocul Surf. 2007;5:108–52.
  • Nelson P. A shorter Schirmer tear test. Optom Mon. 1982;73:568–69.
  • Cho P, Yap M. Schirmer test. II. A clinical study of its repeatability. Optom Vis Sci. 1993;70:157–59.
  • Saleh T, McDermott B, Bates A, Ewings P. Phenol red thread test vs Schirmer‘s test: a comparative study. Eye. 2006;20(8):913–15. doi:10.1038/sj.eye.6702052.
  • Senchyna M, Wax MB. Quantitative assessment of tear production: a review of methods and utility in dry eye drug discovery. J Ocul Biol Dis Infor. 2008;1(1):1–6. doi:10.1007/s12177-008-9006-2.
  • Dougherty BE, Nichols JJ, Nichols KK. Rasch analysis of the ocular surface disease index (OSDI). Invest Ophthalmol Vis Sci. 2011;52(12):8630–35. doi:10.1167/iovs.11-8027.
  • Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the ocular surface disease index. Arch Ophthal. 2000;118:615–21.
  • Li M, Gong L, Chapin WJ, Zhu M. Assessment of vision-related quality of life in dry eye patients. Invest Ophthalmol Vis Sci. 2012;53:5722–27. doi:10.1167/iovs.11-9094.
  • Ünlü C, Güney E, Bis A, Akçalı G, Erdoğan G, Bayramlar H. Comparison of ocular-surface disease index questionnaire, tearfilm break-up time, and Schirmer tests for the evaluation of the tearfilm in computer users with and without dry-eye symptomatology. Clin Ophthalmol. 2012;6:1303–06. doi:10.2147/OPTH.S33588.
  • Rossi GCM, Tinelli C, Pasinetti GM, Milano G, Bianchi PE. Dry eye syndrome-related quality of life in glaucoma patients. Eur J Ophthalmol. 2009;19:572–79.
  • Portello JK, Rosenfield M, Bababekova Y, Estrada JM, Leon A. Computer-related visual symptoms in office workers. Ophthalmic Physiol Opt. 2012;32:375–82. doi:10.1111/j.1475-1313.2012.00925.x.
  • García-Catalán M, Jerez-Olivera E, Benítez-Del-Castillo-Sánchez J. Dry eye and quality of life. Arch Soc Esp Oftalmol. 2009;84:451–58.
  • Sullivan BD, Crews LA, Messmer EM, Foulks GN, Nichols KK, Baenninger P, Geerling G, Figueiredo F, Lemp MA. Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications. Acta Ophthalmol. 2014;92(2):161–66. doi:10.1111/aos.12012.
  • Onwubiko SN, Eze BI, Udeh NN, Onwasigwe EN, Umeh RE. Dry eye disease: concordance between the diagnostic tests in african eyes. Eye Cont Lens. 2015;42(6). www.ingentaconnect.com/content/wk/ecl/2016/00000042/00000006/art00012.
  • Fenga C, Aragona P, Di NC, Spinella R. Comparison of ocular surface disease index and tear osmolarity as markers of ocular surface dysfunction in video terminal display workers. Am J Ophthalmol. 2014;158(1):41–48. e2. doi:10.1016/j.ajo.2014.03.007.
  • Yeotikar NS, Zhu H, Markoulli M, Nichols KK, Naduvilath T, Papas EB. Functional and morphologic changes of meibomian glands in an asymptomatic adult population functional and morphologic changes of meibomian glands. Invest Ophthalmol Vis Sci. 2016;57(10):3996–4007. doi:10.1167/iovs.15-18467.
  • Zou KH, O’Malley AJ, Mauri L. Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models. Circulation. 2007;115(5):654–57. doi:10.1161/CIRCULATIONAHA.105.594929.
  • Beck JR, Shultz EK. The use of relative operating characteristic (ROC) curves in test performance evaluation. Arch Pathol Lab Med. 1986;110:13–20.
  • Ousler III GW, Hagberg KW, Schindelar M, Welch D, Abelson MB. The ocular protection index. Cornea. 2008;27(5):509–13. doi:10.1097/ICO.0b013e31816583f6.
  • Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea. 2003;22:640–50.
  • Geerling G, Tauber J, Baudouin C, Goto E, Matsumoto Y, O‘Brien T, Rolando M, Tsubota K, Nichols KK. The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 2011;52(4):2050–64. doi:10.1167/iovs.10-6997g.
  • Tomlinson A, Khanal S, Ramaesh K, Diaper C, McFadyen A. Tear film osmolarity: determination of a referent for dry eye diagnosis. Invest Ophthalmol Vis Sci. 2006;47(10):4309–15. doi:10.1167/iovs.05-1504.
  • Wolffsohn JS, Arita R, Chalmers R, Djalilian A, Dogru M, Dumbleton K, Gupta PK, Karpecki P, Lazreg S, Pult H, et al. TFOS DEWS II diagnostic methodology report. Ocul Surf. 2017;15(3):539–74. doi:10.1016/j.jtos.2017.05.001.
  • Kim KT, Kim J-H, Kong YT, Chae JB, Hyung S. Reliability of a new modified tear breakup time method: dry tear breakup time. Graefes Arch Clin Exp Ophthalmol. 2015;253(8):1355–61. doi:10.1007/s00417-015-3080-5.
  • Danjo Y. Diagnostic usefulness and cutoff value of Schirmer’s I test in the Japanese diagnostic criteria of dry eye. Graefes Arch Clin Exp Ophthalmol. 1997;235:761–66.
  • Nelson JD, Shimazaki J, Benitez-del-Castillo JM, Craig JP, McCulley JP, Den S, Foulks GN. The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee. Invest Ophthalmol Vis Sci. 2011;52(4):1930–37. doi:10.1167/iovs.10-6997b.
  • Tomlinson A, Bron AJ, Korb DR, Amano S, Paugh JR, Pearce EI, Yee R, Yokoi N, Arita R, Dogru M. The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee. Invest Ophthalmol Vis Sci. 2011;52(4):2006–49. doi:10.1167/iovs.10-6997f.
  • Pult H, Purslow C, Murphy PJ. The relationship between clinical signs and dry eye symptoms. Eye. 2011;25(4):502–10. doi:10.1038/eye.2010.228.
  • Sweeney DF, Millar TJ, Raju SR. Tear film stability: a review. Exp Eye Res. 2013;117:28–38. doi:10.1016/j.exer.2013.08.010.
  • Luce DA Method and apparatus for tear film measurement. Google Patents; 2010.
  • Nichols JJ, Nichols KK, Puent B, Saracino M, Mitchell GL. Evaluation of tear film interference patterns and measures of tear break-up time. Optom Vis Sci. 2002;79:363–69.
  • Cho P, Douthwaite W. The relation between invasive and noninvasive tear break-up time. Optom Vis Sci. 1995;72:17–22.
  • Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiol. 1982;143(1):29–36. doi:10.1148/radiology.143.1.7063747.
  • Norn M. Desiccation of the precorneal film. Acta Ophthalmol. 1969;47(4):865–80. doi:10.1111/j.1755-3768.1969.tb03711.x.
  • Lee JH, Kee CW. The significance of tear film break-up time in the diagnosis of dry eye syndrome. Korean J Ophthalmol. 1988;2(2):69–71. doi:10.3341/kjo.1988.2.2.69.
  • Jiang Y, Ye H, Xu J, Lu Y. Noninvasive keratograph assessment of tear film break-up time and location in patients with age-related cataracts and dry eye syndrome. J Int Med Res. 2014;42(2):494–502. doi:10.1177/0300060513504701.
  • Abelson MB, Ousler GW, Nally LA, Welch D, Krenzer K. Alternative reference values for tear film break up time in normal and dry eye populations. Lacrimal Gland Tear Film Dry Eye Syndromes. 2002;3:1121–25. Springer.
  • Vitali C, Moutsopoulos HM, Bombardieri S. The european community study group on diagnostic criteria for Sjögren‘s syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren‘s syndrome. Ann Rheum Dis. 1994;53:637–47.
  • Alves M, Reinach PS, Paula JS, e Cruz AAV, Bachette L, Faustino J, Aranha FP, Vigorito A, de Souza CA, Rocha EM. Comparison of diagnostic tests in distinct well-defined conditions related to dry eye disease. PLos One. 2014;9(5):e97921. doi:10.1371/journal.pone.0097921.
  • Lin P-Y, Cheng C-Y, Hsu W-M, Tsai S-Y, Lin M-W, Liu J-H CP. Association between symptoms and signs of dry eye among an elderly Chinese population in Taiwan: the Shihpai eye study. Invest Ophthalmol Vis Sci. 2005;46(5):1593–98. doi:10.1167/iovs.04-0864.
  • Begley CG, Caffery B, Chalmers RL, Mitchell GL. Use of the dry eye questionnaire to measure symptoms of ocular irritation in patients with aqueous tear deficient dry eye. Cornea. 2002;21:664–70.
  • Korb DR, Blackie CA. Meibomian gland diagnostic expressibility: correlation with dry eye symptoms and gland location. Cornea. 2008;27(10):1142–47. doi:10.1097/ICO.0b013e3181814cff.
  • Savini G, Prabhawasat P, Kojima T, Grueterich M, Espana E, Goto E. The challenge of dry eye diagnosis. Clin Ophthalmol. 2008;2:31–55.
  • Johnson ME. The association between symptoms of discomfort and signs in dry eye. Ocul Surf. 2009;7:199–211.
  • Vroman DT, Sandoval HP, Fernández de Castro LE, Kasper TJ, Holzer MP, Solomon KD. Effect of hinge location on corneal sensation and dry eye after laser in situ keratomileusis for myopia. J Cataract Refract Surg. 2005;31(10):1881–87. doi:10.1016/j.jcrs.2005.03.074.
  • Knottnerus JA, Tugwell P. Inter-population differences in measuring: appreciation by adaptation. J Clin Epidemiol. 2015;68(4):357–59. doi:10.1016/j.jclinepi.2015.02.004.
  • Santo RM, Ribeiro-Ferreira F, Alves MR, Epstein J, Novaes P. Enhancing the cross-cultural adaptation and validation process: linguistic and psychometric testing of the Brazilian–Portuguese version of a self-report measure for dry eye. J Clin Epidemiol. 2015;68(4):370–78. doi:10.1016/j.jclinepi.2014.07.009.
  • Grubbs JR Jr, Tolleson-Rinehart S, Huynh K, Davis RM. A review of quality of life measures in dry eye questionnaires. Cornea. 2014;33(2):215. doi:10.1097/ICO.0000000000000038.
  • Zeev MS-B, Miller DD, Latkany R. Diagnosis of dry eye disease and emerging technologies. Clin Ophthalmol. 2014;8:581–90. doi:10.2147/OPTH.S45444.
  • Yoon K-C, Park C-S, You I-C, Choi H-J, Lee K-H, Im S-K, Park H-Y, Pflugfelder SC. Expression of CXCL9,-10,-11, and CXCR3 in the tear film and ocular surface of patients with dry eye syndrome. Invest Ophthalmol Vis Sci. 2010;51(2):643–50. doi:10.1167/iovs.09-3425.
  • Choi W, Li Z, Oh H-J, Im S-K, Lee S-H, Park S-H, You I-C, Yoon K-C. Expression of CCR5 and its ligands CCL3,-4, and-5 in the tear film and ocular surface of patients with dry eye disease. Curr Eye Res. 2012;37(1):12–17. doi:10.3109/02713683.2011.622852.
  • Boehm N, Riechardt AI, Wiegand M, Pfeiffer N, Grus FH. Proinflammatory cytokine profiling of tears from dry eye patients by means of antibody microarrays. Invest Ophthalmol Vis Sci. 2011;52(10):7725–30. doi:10.1167/iovs.11-7266.
  • Meadows JF, Dionne K, Nichols KK. Differential profiling of T-cell cytokines as measured by protein microarray across dry eye subgroups. Cornea. 2016;35(3):329–35. doi:10.1097/ICO.0000000000000721.
  • Yoon K-C, Jeong I-Y, Park Y-G, Yang S-Y. Interleukin-6 and tumor necrosis factor-α levels in tears of patients with dry eye syndrome. Cornea. 2007;26(4):431–37. doi:10.1097/ICO.0b013e31803dcda2.
  • Lam H, Bleiden L, De Paiva CS, Farley W, Stern ME, Pflugfelder SC. Tear cytokine profiles in dysfunctional tear syndrome. Am J Ophthalmol. 2009;147(2):198–205. e1. doi:10.1016/j.ajo.2008.08.032.
  • Ji YW, Mittal SK, Hwang HS, Chang E-J, Lee JH, Seo Y, Yeo A, Noh H, Lee HS, Chauhan SK. Lacrimal gland–derived IL-22 regulates IL-17-mediated ocular mucosal inflammation. Mucosal Immunol. 2017;10(5):1202. doi:10.1038/mi.2016.119.
  • Massingale ML, Li X, Vallabhajosyula M, Chen D, Wei Y, Asbell PA. Analysis of inflammatory cytokines in the tears of dry eye patients. Cornea. 2009;28(9):1023–27. doi:10.1097/ICO.0b013e3181a16578.
  • Acera A, Vecino E, Duran JA. Tear MMP-9 levels as a marker of ocular surface inflammation in conjunctivochalasis. Invest Ophthalmol Vis Sci. 2013;54(13):8285–91. doi:10.1167/iovs.13-12235.
  • Messmer EM, von Lindenfels V, Garbe A, Kampik A. Matrix metalloproteinase 9 testing in dry eye disease using a commercially available point-of-care immunoassay. Ophthalmol. 2016;123(11):2300–08. doi:10.1016/j.ophtha.2016.07.028.
  • Sambursky R, Davitt III WF, Friedberg M, Tauber S. Prospective, multicenter, clinical evaluation of point-of-care matrix metalloproteinase-9 test for confirming dry eye disease. Cornea. 2014;33(8):812–18. doi:10.1097/ICO.0000000000000175.
  • Walter SD, Gronert K, McClellan AL, Levitt RC, Sarantopoulos KD, Galor A. ω-3 tear film lipids correlate with clinical measures of dry eye. Invest Ophthalmol Vis Sci. 2016;57(6):2472–78. doi:10.1167/iovs.16-19131.
  • Kenchegowda S, He J, Bazan H. Involvement of pigment epithelium-derived factor, docosahexaenoic acid and neuroprotectin D1 in corneal inflammation and nerve integrity after refractive surgery. Prostaglandins Leukotrienes Essent Fatty Acids. 2013;88(1):27–31. doi:10.1016/j.plefa.2012.03.010.
  • Zhou L, Beuerman RW. Quantitative proteomic analysis of N-linked glycoproteins in human tear fluid. Mass spectrometry of glycoproteins. Springer; 2013. p. 297–306.
  • Tong L, Zhou L, Beuerman RW, Zhao SZ, Li XR. Association of tear proteins with Meibomian gland disease and dry eye symptoms. Br J Ophthalmol. 2011;95(6):848–52. doi:10.1136/bjo.2010.185256.
  • Tamhane M, Cabrera-Ghayouri S, Abelian G, Viswanath V. Review of biomarkers in ocular matrices: challenges and opportunities. Pharm Res. 2019;36(3):40. doi:10.1007/s11095-019-2599-2.